June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Inner retinal layer and choroidal thickness in patients with type 1 diabetes mellitus with and without retinopathy
Author Affiliations & Notes
  • Marc Carbonell Puig
    Ophthalmology, Hospital Universitari Germans Trias i Pujol, Barcelona, Barcelona, Spain
  • Xavier Valldeperas
    Ophthalmology, Hospital Universitari Germans Trias i Pujol, Barcelona, Barcelona, Spain
  • Nuria Alonso
    Ophthalmology, Hospital Universitari Germans Trias i Pujol, Barcelona, Barcelona, Spain
  • Esmeralda Castelblanco
    Ophthalmology, Hospital Universitari Germans Trias i Pujol, Barcelona, Barcelona, Spain
  • Alicia Traveset
    Hospital Universitari Arnau de Vilanova, Lleida, Spain
  • Carmen Jurjo
    Hospital Universitari Arnau de Vilanova, Lleida, Spain
  • Dídac Mauricio
    Ophthalmology, Hospital Universitari Germans Trias i Pujol, Barcelona, Barcelona, Spain
  • Footnotes
    Commercial Relationships   Marc Carbonell Puig, None; Xavier Valldeperas, None; Nuria Alonso, None; Esmeralda Castelblanco, None; Alicia Traveset, None; Carmen Jurjo, None; Dídac Mauricio, None
  • Footnotes
    Support  NONE
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 5030. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Marc Carbonell Puig, Xavier Valldeperas, Nuria Alonso, Esmeralda Castelblanco, Alicia Traveset, Carmen Jurjo, Dídac Mauricio; Inner retinal layer and choroidal thickness in patients with type 1 diabetes mellitus with and without retinopathy. Invest. Ophthalmol. Vis. Sci. 2017;58(8):5030.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate changes in retinal nerve fiber layer (RNFL), ganglion cell/inner plexiform layer (GC/IPL) and choroidal thickness (CT) in type 1 diabetic patients using enhanced-depth imaging spectral-domain optical coherence tomography (EDI-OCT).

Methods : Patients with type 1 diabetes mellitus and no macular edema were recruited for this cross-sectional study. Exclusion criteria included refractive error ≥5.00 diopters and/or other retinal diseases, as well as history of previous cardiovascular events or chronic kidney disease. All patients underwent a complete ophthalmologic examination, including automatic segmentation of the retinal layers using EDI-OCT (Cirrus 4000. Zeiss) and manual measurement of the CT using the software’s caliper tool, at three different points: subfoveal, 1000µm nasal and temporal from the subfoveal line.

Results : 514 eyes of 257 patients were included in the study. Mean age was 45±11 years, 54.1% were female, mean diabetes duration was 20.3±10.8 and mean HbA1c was 7.4±1.0. No signs of diabetic retinopathy (DR) were observed in 54.9% of the patients, and the rest were classified into mild DR (62.1%), moderate DR (12.5%), severe DR (13.4%) and proliferative DR (7.3%). Patients with DR were older (p=0.001) and had previous cataract surgery more frequently (p=0.001). Patients with proliferative DR showed thicker RNFL (Figure 1), but these differences were only statistically significant in the temporal subfield (p=0.020). GCL/IPL thickness significantly decreased with the worsening of the DR severity. Similarly, CT is inversely correlated to DR worsening, except for the proliferative stage when choroid is thicker than in patients without DR (Figure 2).

Conclusions : Large controversy exists in the literature, and contradictory results have been published, regarding the role of the choroid in the pathophysiology of DR and macular edema. We report a decrease in CT with increasing severity of DR, but a significant increase in proliferative DR patients. This could be explained by the overexpression of VEGF in proliferative eyes with subsequent choroidal vasodilation and increased blood flow and thickness of this layer. Our study also shows a significant thinning of the GCL/IPL in eyes with more severe DR, suggesting a potential neurodegenerative damage of the retina even in early stages of DR.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×